C-Reactive protein (CRP} should be measured in all patients undergo
ing coronary angtoplastyforprognostic stratification. Preprocedural levels
are ofproved efficacy. CRP levels can be used as a guide to therapy in
PCI.
The aimofthis study is to evaluate thepredictive value ofCRPplasma
levelfor coronary instent restenosis (ISR).
This study included GO patients who underwent successful coronary
stenting .Allpatients included in this study were subjected to thefollow
ing:
' Full history taking, thorough clinical examination, riskfactors evalua
tion, 12 leads surface ECG, plain chest x-ray echocardiography , cor
onary angiography and laboratory investigations (Blood sugar level,
lipidprofile and CRP)withfollowupperiodfor sixmonth.
-Patients were classified into two groups according to ISR
*Group (I) with ISR included 22 patients (43.1%) and 22 lesions
treated with 25 stents (45%).
•Group (II) without ISR included 29 patients (59.9%) with 29 lesions
treated with 30 stents (55%;.
-Atfollowup,focal ISR(<10mm) was detected in 5 patients (22.7%).
diffuse (>10 mm) in 7patients (31.8%), proliferative ISR in 5 patients
(22.7%) and total occlusion in 5patiients (22.7%;.
-In restenotic group (I) 8patients (36.4%) were asymptomatic, two pa
tients (9.1%) had unstable angina and 12 patients (54.5%) had
stable angina. |
